Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Breast Neoplasms, Male × Immunotherapy × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms, Male 1 Breast Neoplasms 1

Interventions

Propranolol 1 Neoadjuvant Therapy 1 Microscopy, Electron 1 Immunotherapy 1 Fluorodeoxyglucose F18 1 Echocardiography 1 Cyclophosphamide 1 Cryosurgery 1 CYT-6091 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03387553 2026-02-09

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Active not recruiting

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡